000 01204 a2200325 4500
005 20250518072907.0
264 0 _c20210129
008 202101s 0 0 eng d
022 _a1130-0108
024 7 _a10.17235/reed.2019.6554/2019
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aValdivielso Cortázar, Eduardo
245 0 0 _aCrohn's disease in patients treated with etanercept.
_h[electronic resource]
260 _bRevista espanola de enfermedades digestivas
_c01 2020
300 _a80-81 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aAdult
650 0 4 _aCrohn Disease
_xchemically induced
650 0 4 _aDrug Substitution
650 0 4 _aEtanercept
_xadverse effects
650 0 4 _aHumans
650 0 4 _aInfliximab
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aSpondylitis, Ankylosing
_xdrug therapy
650 0 4 _aTumor Necrosis Factor-alpha
_xantagonists & inhibitors
700 1 _aDiz-Lois Palomares, Maria Teresa
700 1 _aAlonso Aguirre, Pedro
773 0 _tRevista espanola de enfermedades digestivas
_gvol. 112
_gno. 1
_gp. 80-81
856 4 0 _uhttps://doi.org/10.17235/reed.2019.6554/2019
_zAvailable from publisher's website
999 _c30377676
_d30377676